Qi Diagnostics Wins Best Rising Star of the Year – Excellence in Product Innovation at the HKMA/ HKT Global Innovation Award 2024/25
(24 Jan 2025)
Qi Diagnostics Wins Best Rising Star of the Year – Excellence in Product Innovation at the HKMA/HKT Global Innovation Award 2024/25
(Hong Kong – January 23, 2025) Qi Diagnostics is proud to announce that it has been awarded Champion and recognized as the Best Rising Star of the Year – Excellence in Product Innovation at the prestigious HKMA/HKT Global Innovation Award 2024/25.
After rigorous evaluation by an esteemed panel of over ten international judges, Qi Diagnostics’ innovative approach to healthcare technology stood out among the Top 10 Winners, earning the highest accolade of the event.
During the award acceptance speech, Grover Cheung, Founder of Qi Diagnostics, said:
“This recognition highlights not just our innovation but also our commitment to making a real impact. At Qi Diagnostics, we have developed a groundbreaking breath test capable of detecting lung cancer tumors with over 94% accuracy, even at stage 1. Our goal extends beyond technology—we are focused on expanding partnerships and collaborations to bring this solution to markets worldwide. This success is the result of our incredible team, the trust of our partners, and the support of everyone who shares our vision for a healthier future. Thank you again for this incredible honor.”
Qi Diagnostics continues to lead the way in healthcare innovation with its Lung Cancer Breathalyzer, a non-invasive diagnostic tool with over 94% accuracy, and the KetoAir, a portable diet breathalyzer pen already sold in the United States. These innovations reflect the company’s dedication to advancing Hong Kong’s status as a global leader in health technology.
For more information about Qi Diagnostics and its groundbreaking innovations, please visit www.qidiagnostics.com.
氣葩科技於「HKMA/HKT全球創新大獎2024/25」中榮獲「年度最佳新星——卓越產品創新大獎」 2024/25，展望創新突破
（2024年1月24日）
氣葩科技（Qi Diagnostics）榮獲「HKMA/HKT全球創新大獎2024/25」的最高榮譽，成功奪得 「年度最佳新星——卓越產品創新大獎」。
經過超過十位國際評審的嚴格評選，氣葩科技在十大得獎者中脫穎而出，獲得本次盛事的最高殊榮。
在領獎時，氣葩科技創辦人張煒鋒先生（Grover Cheung）表示： 「這項殊榮不僅彰顯了我們的創新能力，也反映了我們對社會影響的承諾。氣葩科技成功研發了一種突破性的肺癌呼氣檢測儀，準確率超過94%，甚至可以在癌症第一期進行檢測。我們的目標不僅在於技術突破，更致力於拓展全球合作，將這項技術帶到更多市場。這份成功歸功於我們卓越的團隊、合作夥伴的信任，以及每一位支持我們更健康未來願景的人士。」
氣葩科技以其創新技術繼續領航醫療科技，包括準確率超過94%的肺癌呼氣檢測儀，以及便攜式飲食呼氣測試筆KetoAir（已於美國售出超過1000支）。這些突破性產品進一步奠定了香港科研品牌在全球健康科技領域的領導地位。
如需了解更多關於氣葩科技及其創新技術的資訊，請訪問www.qidiagnostics.com。
